Tempus AI gets FDA clearance for ECG-based AI pulmonary hypertension tool
Go back to Tempus AI gets FDA clearance for ECG-based AI pulmonary hypertension tool| StemCells, Inc. (NASDAQ: TEM) | Delayed: 77.19 -0.84 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.03 | 52 Week High | $0.45 | |||
| Open | $77.99 | 52 Week Low | $0.37 | |||
| Day High | $79.00 | P/E | N/A | |||
| Day Low | $75.81 | EPS | $-0.31 | |||
| Volume | 5,995,237 | |||||
